Molecular structure of Notoginsenoside R1, CAS Number: 80418-24-2
Notoginsenoside R1 (CAS 80418-24-2)
Application:
Notoginsenoside R1 is a biochemical for proteomics research
CAS Number:
80418-24-2
Purity:
≥98%
Molecular Weight:
933.13
Molecular Formula:
C47H80O18
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Notoginsenoside R1 is an active ingredient isolated from Panax notoginseng that induces tissue-type plasminogen activator synthesis in cultured human umbilical vein endothelial cells.
Notoginsenoside R1 (CAS 80418-24-2) References
- Notoginsenoside R1 Ameliorates Diabetic Retinopathy through PINK1-Dependent Activation of Mitophagy. | Zhou, P., et al. 2019. Cells. 8: PMID: 30832367
- Focus on Notoginsenoside R1 in Metabolism and Prevention Against Human Diseases. | Liu, H., et al. 2020. Drug Des Devel Ther. 14: 551-565. PMID: 32103897
- Notoginsenoside R1 attenuates sevoflurane-induced neurotoxicity. | Zhang, Y., et al. 2020. Transl Neurosci. 11: 215-226. PMID: 33335762
- Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction. | Li, H., et al. 2022. Redox Biol. 54: 102384. PMID: 35777198
- Pharmacological properties and mechanisms of Notoginsenoside R1 in ischemia-reperfusion injury. | Zhu, T. and Wan, Q. 2023. Chin J Traumatol. 26: 20-26. PMID: 35922249
- Notoginsenoside R1 protects against myocardial ischemia/reperfusion injury in mice via suppressing TAK1-JNK/p38 signaling. | Zeng, JJ., et al. 2023. Acta Pharmacol Sin. 44: 1366-1379. PMID: 36721009
- Notoginsenoside R1 inhibits hepatitis B virus replication by modulating SIRT1 activity. | Zhang, W., et al. 2023. Acta Virol. 67: 51-58. PMID: 36950885
- Notoginsenoside R1 protects against hypobaric hypoxia-induced high-altitude pulmonary edema by inhibiting apoptosis via ERK1/2-P90rsk-BAD ignaling pathway. | Pei, C., et al. 2023. Eur J Pharmacol. 959: 176065. PMID: 37775017
- Notoginsenoside R1 alleviates cerebral ischemia/reperfusion injury by inhibiting the TLR4/MyD88/NF-κB signaling pathway through microbiota-gut-brain axis. | Zhang, S., et al. 2024. Phytomedicine. 128: 155530. PMID: 38493723
- Effect of notoginsenoside R1 on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells. | Zhang, W., et al. 1994. Arterioscler Thromb. 14: 1040-6. PMID: 8018658
Activator of:
Srs2.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Notoginsenoside R1, 5 mg | sc-205772 | 5 mg | $141.00 | |||
Notoginsenoside R1, 10 mg | sc-205772A | 10 mg | $204.00 |